You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pemetrexed

Showing 1 - 25 of 448
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mesothelioma Trial in Houston (Pemetrexed, Cisplatin)

Terminated
  • Mesothelioma
  • Houston, Texas
    Baylor St Lukes
Mar 15, 2022

CNS Lymphoma Trial in Zhengzhou (ICP-022, Pemetrexed)

Recruiting
  • Central Nervous System Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jan 28, 2022

Leptomeningeal Metastasis Trial in Changchun (Pemetrexed, Radiotherapy)

Recruiting
  • Leptomeningeal Metastasis
  • Pemetrexed
  • Radiotherapy
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Jun 8, 2022

Adenocarcinoma of Lung, NSCLC Trial in Rolling Meadows (LP-300, Pemetrexed, Carboplatin)

Not yet recruiting
  • Adenocarcinoma of Lung
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Jul 8, 2022

Advanced Cancers Trial in Houston (Crizotinib (Xalkori), Pazopanib, Pemetrexed)

Terminated
  • Advanced Cancers
  • Crizotinib (Xalkori)
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 3, 2021

Non-Small-Cell Lung Carcinoma Trial (biological, drug, dietary supplement)

Active, not recruiting
Has Results
  • Non-Small-Cell Lung Carcinoma
  • Pembrolizumab 200 mg
  • +7 more
  • (no location specified)
Aug 16, 2022

Lung Cancer Trial in Nashville (Pemetrexed, Gemcitabine)

Completed
Has Results
  • Lung Cancer
  • Nashville, Tennessee
    Tennessee Oncology
Feb 21, 2022

Lung Adenocarcinoma, Cryotherapy Effect Trial in Bordeaux (Cryoablation, Pembrolizumab, Pemetrexed)

Recruiting
  • Lung Adenocarcinoma
  • Cryotherapy Effect
  • Cryoablation
  • +3 more
  • Bordeaux, Gironde, France
    Institut Bergonié
Oct 29, 2021

NSCLC Metastatic Trial in Salt Lake City (Durvalumab, Pemetrexed, Carboplatin)

Recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • Salt Lake City, Utah
    Huntsman Cancer Institute at University of Utah
Mar 1, 2022

Non Small Cell Lung Cancer, Non-squamous Non-small-cell Lung Cancer, Urothelial Carcinoma Trial in Augusta (Cabozantinib,

Recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • Augusta, Georgia
    Augusta University Georgia Cancer Center
Mar 6, 2022

Glioma, Brain Metastases Trial in Shanghai (Autologous progenitor expansion -T, pemetrexed)

Recruiting
  • Glioma
  • Brain Metastases
  • Autologous progenitor expansion -T
  • pemetrexed
  • Shanghai, Shanghai, China
    Fudan University Pudong Medical Center
Jul 12, 2022

Lung Cancer Trial in Houston (AMG 510, Cisplatin, Carboplatin)

Recruiting
  • Lung Cancer
  • AMG 510
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 30, 2022

Metastatic NSCLC, Stage III NSCLC Trial (inupadenant, Placebo, Carboplatin)

Not yet recruiting
  • Metastatic NSCLC
  • Stage III NSCLC
  • (no location specified)
Aug 1, 2022

Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma With Glandular

Recruiting
  • Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2021

NSCLC Trial in Gyeonggi-do, Incheon, Seoul (Lazertinib, Pemetrexed, Carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Gyeonggi-do, Korea, Republic of
  • +5 more
Jul 25, 2022

NSCLC Trial (Bemcentinib, Pembrolizumab, Pemetrexed)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Jul 19, 2022

Urothelial Carcinoma, Metastatic Cancer Trial in Houston (Pemetrexed, Zimberelimab, Etrumadenant)

Not yet recruiting
  • Urothelial Carcinoma
  • Metastatic Cancer
  • Pemetrexed
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Apr 19, 2022

Alvopem® (Pemetrexed) Safety Assessment

Completed
  • Non Small Cell Lung Cancer
  • Malignant Pleural Mesothelioma
  • Pemetrexed
  • (no location specified)
Apr 10, 2021

NSCLC Trial in Tianjin (Tislelizumab, Pemetrexed, Bevacizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jul 11, 2022

Non Small Cell Lung Cancer Trial in Tianjin (Osimertinib, Bevacizumab Biosimilar IBI305, Carboplatin)

Recruiting
  • Non Small Cell Lung Cancer
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Aug 18, 2022

NSCLC Trial in Chalon-sur-Saône, Dijon (Pemetrexed)

Completed
  • Non-small Cell Lung Cancer
  • Pemetrexed
  • Chalon-sur-Saône, France
  • +2 more
May 21, 2021

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Chicago (Pemetrexed)

Completed
  • Brain and Central Nervous System Tumors
  • +10 more
  • Pemetrexed
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Sep 3, 2021

Non-Squamous NSCLC Trial in Shanghai (Sintilimab, IBI305, Pemetrexed)

Recruiting
  • Non-Squamous Non-Small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Jan 18, 2022

Advanced Lung Non-Small Cell Carcinoma, Non-Small Cell Carcinoma of Lung, TNM Stage 4 Trial in Boston (Granulocyte-Macrophage

Recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • Non-Small Cell Carcinoma of Lung, TNM Stage 4
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • +4 more
  • Boston, Massachusetts
    Tufts Medical Center
Jan 5, 2022

Advanced NSCLC, KRAS Gene Mutation, Lung Cancer Trial in Switzerland (Binimetinib, Pemetrexed, Cisplatin)

Completed
  • Advanced Non-small Cell Lung Cancer
  • +2 more
  • Basel, Switzerland
  • +3 more
Jul 13, 2021